# LumenAI — Controlled Pilot Report (LPR-DIR-021, Phase 10)

**Program:** Operational Excellence — Phase 10: Controlled Pilot Execution & Clinical
Validation Readiness. **Assessment/planning only. No application code, features, or
deployment changed; v1.0 architecture frozen. No general deployment, clinical, or
regulatory claim authorized.**

---

## ⚠️ Governing determination (honesty mandate)

The directive asks to "plan, execute, and evaluate a controlled pilot." **The pilot was
planned but NOT executed** — real-world preconditions do not exist (no site, no
clinical users, no managed environment, **zero real facility images**), and execution
is gated by 1 CRITICAL (SEC-C-01) + 8 HIGH blockers. This is consistent with the
existing `docs/clinical-pilot/PILOT_EXECUTION_STATUS.md` (**PILOT_NOT_EXECUTED**).
Every pilot *result* (workflow deviations, operator feedback, throughput, data quality,
pilot AI-governance) is therefore **NOT AVAILABLE — pilot not executed**, and is not
fabricated. What is delivered is a complete, real **execution plan + readiness + entry
gate + risk register**.

## 1. Executive Summary

The controlled pilot is **thoroughly planned and the software is regression-tested**
(Pilot Alpha 130/130), but **no pilot ran** and none can until (a) V1.1 security/
operability hardening closes and (b) a real site + users + managed environment are
engaged. Pilot outcomes cannot be reported without fabrication and are marked NOT
AVAILABLE. AI-governance controls (advisory-only, mandatory human review, honest
Unknown/confidence) are **verified in software** — the central safety guarantee for a
future pilot.

## 2. Pilot Objectives
Observe-only workflow/operational evidence (integration, usability, stability,
throughput, data quality, review efficiency) — **no clinical performance measurement**.
Plan, sites criteria, users, inclusion/exclusion, governance, and metrics are defined
(`PILOT_EXECUTION_PLAN.md`).

## 3. Workflow Validation
Software workflow **validated (tested)** across inspection/annotation/evidence/Digital
Twin/reporting; real-world pilot workflow **NOT VALIDATED — no pilot**, so **no
deviations** can be reported (`WORKFLOW_VALIDATION_REPORT.md`).

## 4. User Experience
**NOT AVAILABLE — no operators.** Design-level UX review + feedback instruments +
training material are ready; in-product feedback instrumentation is a prerequisite gap
(`USER_EXPERIENCE_REPORT.md`).

## 5. Performance Summary
**NOT AVAILABLE — no pilot / no production-representative env.** Only non-production
micro-benchmarks exist (`/health` p99 8.93 ms — a test-client artifact, not capacity);
PERF-07 production load test still open; metrics under-instrumented
(`PILOT_PERFORMANCE_REPORT.md`).

## 6. Data Quality
**NOT AVAILABLE — zero real facility images.** Data-quality *controls* (image-quality
assessment, metadata standard, double-blind review, GT governance, hash-chained audit)
are real and test-verified on synthetic data only (`DATA_QUALITY_REPORT.md`).

## 7. AI Governance
Controls **verified in software**: AI advisory/observe-only (structurally no autonomous
decisions), mandatory human review, Unknown/Unable-to-Determine valid, reviewer
confidence ≠ AI certainty. Pilot-operation verification NOT AVAILABLE (no pilot). Only
registered model is **Experimental / synthetic — not a trained CV model**
(`AI_GOVERNANCE_PILOT_REPORT.md`).

## 8. Risk Register
No observed pilot incidents (none ran). Execution-blocking preconditions: PB-01
SEC-C-01 (CRITICAL) + PB-02..08 (HIGH/operational). Anticipated pilot risks PR-01..07
with mitigations (`PILOT_RISK_REGISTER.md`).

## 9. Executive Review
Software-ready, pilot-planned, **not pilot-ready to execute**; broader deployment is
two gates away (V1.1 hardening → run+pass a controlled pilot). Neither a pilot launch
nor general deployment is authorized (`EXECUTIVE_PILOT_REVIEW.md`).

## 10. Recommendations
1. **Close V1.1 hardening** (SEC-C-01 + 8 HIGH) + build measurement/feedback
   instrumentation.
2. **Provision a managed, production-representative environment** and smoke-verify.
3. **Engage a real site**; train + competency-sign operators; validate equipment; seed
   governed baselines + Digital Twins.
4. **Then execute the controlled pilot** under `PILOT_EXECUTION_PLAN.md`, capturing
   evidence via the prepared forms; report only real records (`insufficient_data`
   otherwise).
5. **Keep AI observe-only**; make no clinical/regulatory/performance claim.

## Operational Decision

Of the exit states — **PILOT SUCCESSFUL / SUCCESSFUL WITH FOLLOW-UP / ADDITIONAL PILOT
REQUIRED** — **none applies, because no pilot was executed.** The honest determination:

> ## ⚪ PILOT NOT EXECUTED — READINESS PLANNED, EXECUTION GATED
>
> A complete, real execution plan, readiness assessment, entry gate, and risk register
> exist. The controlled pilot **has not run and cannot run** until the entry gate
> closes (V1.1 hardening + managed environment + real site/users/equipment). Declaring
> the pilot "successful" (or even "additional pilot required") would presuppose a pilot
> that never happened — a fabrication. **No pilot result is reported; no general
> deployment, clinical, or regulatory claim is authorized.**

## 11. Deliverables index

| # | File | Honest status |
|---|---|---|
| 1 | `PILOT_EXECUTION_PLAN.md` | Real plan + entry gate |
| 2 | `WORKFLOW_VALIDATION_REPORT.md` | Software tested; real-world NOT AVAILABLE |
| 3 | `USER_EXPERIENCE_REPORT.md` | NOT AVAILABLE (no operators) |
| 4 | `PILOT_PERFORMANCE_REPORT.md` | NOT AVAILABLE (no pilot/env) |
| 5 | `DATA_QUALITY_REPORT.md` | NOT AVAILABLE (no real images); controls real |
| 6 | `AI_GOVERNANCE_PILOT_REPORT.md` | Controls verified; pilot-op NOT AVAILABLE |
| 7 | `PILOT_RISK_REGISTER.md` | Blockers + anticipated risks |
| 8 | `EXECUTIVE_PILOT_REVIEW.md` | Readiness review, not outcomes |
| 9 | `LUMENAI_CONTROLLED_PILOT_REPORT.md` | This master roll-up |

---

**Bottom line:** Phase 10 delivers an honest, evidence-based pilot **readiness** package
— not a pilot result. No pilot metrics fabricated; no Critical finding hidden or
downgraded; no pilot launch, general deployment, clinical, or regulatory claim
authorized.
